Cargando…
Variation in Medicaid and commercial coverage of cell and gene therapies
Growth in the availability of cell and gene therapies (CGTs) promises significant innovation in the treatment of serious diseases, but the high cost and one-time administration of CGTs has also raised concern about strain on health plan budgets and inequity in access. We used coverage information fr...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660088/ https://www.ncbi.nlm.nih.gov/pubmed/38023441 http://dx.doi.org/10.1016/j.hpopen.2023.100103 |